The Flow Cytometry Core Facility of the National Human Genome Research Institute has the goal of providing all NHGRI investigators with access to high quality flow cytometry services. The Core serves to enhance the scope and quality of scientific research performed by the Institute. In FY2012, the NHGRI Flow Cytometry Core was staffed by Stacie Anderson (Core Director, 100% effort, GMBB), and Martha Kirby (100% GMBB). The Core post-bac IRTA position is currently vacant and will remain unfilled for the foreseeable future. The Flow Cytometry Core is staffed Monday through Friday and is available to authorized users after regular working hours and on weekends/holidays through key-card access. The NHGRI Flow Cytometry Core currently maintains two BD FACSArias that are primarily used for sorting cells. Each FACSAria is configured with three lasers and can measure up to nine fluorescent parameters as well as physical parameters (size and granularity). The purchase of a fourth 561nm laser was approved in FY2011 and the laser will be installed on the newer of the two Arias. It is anticipated that this installation will occur before the end of the fiscal year. This laser will allow us to detect the red fluorescent proteins with more efficiency and minimize compensation in the red channels. Among the various applications over the past year, the sorting capabilities have been used for isolation of tissue cell populations for animal transplantation experiments;isolation of blood cell sub-populations for analysis of functional cellular properties and gene transcription profiles, as well as high throughput screening of enhancer regions. The FACSArias are operated by the Core Staff, typically have a two-week sign up waiting time and are currently used at near capacity. For direct flow cytometry analysis applications not involving cell sorting, the Flow Core offers two BD FACSCaliburs and one BD LSRII. The FACSCalibur instruments can measure up to four fluorescent parameters, and are routinely used for data acquisition and pre-sort analysis. Due to budget restraints, FACSCalibur E0807 has been removed from service contract saving the Core $10,000 in FY11 and will be traded in to BD and the assets ($10,000) will be used towards the purchase of the 561nm laser. Typical uses of the FACSCaliburs include analysis of GFP expression and cell cycle, as well as mutagenesis screening. The BD LSRII uses digital electronics and Diva software similar to the Aria and is used to perform 9-color analyses. This allows investigators to characterize cells in more detail before sorting on the Aria. The instrument is equipped with a High Throughput Sample (HTS) device gives the investigator the ability to analyze many samples in 96-well plate format without the need of sitting at the instrument during the acquisition procedure. The Flow Core maintains a CompuCyte iCys laser scanning cytometer (LCS). The LSC uses laser-based opto-electronics and automated analysis capabilities to simultaneously and rapidly measure biochemical constituents and evaluate cell morphologies. Current applications (100%) are focused on zebra fish projects including drug screens and blood development. The Flow Core also maintains a Miltenyi Auto MACS that is used for magnetic cell separations. The AutoMACS is often used as a pre-enrichment step prior to sorting on a flow cytometer. The FACSCaliburs, BD LSRII, iCys and Auto Macs are available during regular Core hours as well as after hours and on weekends. Over the past year, the services and capabilities of the NHGRI Flow Core have been taken advantage of by 60 trainees from 5 Branches/14 Sections in the Institute. In addition, the Flow Core continued to maintain CLIA accreditation in support of immunophenotype and protein expression studies used in NHGRI clinical research protocols. Core Statistics (FY12): NHGRI Branches served: 5 NHGRI Investigators served: 60 Recorded Core Visits: 963 Number of sorts: 238

National Institute of Health (NIH)
National Human Genome Research Institute (NHGRI)
Scientific Cores Intramural Research (ZIC)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Human Genome Research Institute
Zip Code
Psaila, Bethan; Barkas, Nikolaos; Iskander, Deena et al. (2016) Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways. Genome Biol 17:83
Vilboux, Thierry; Malicdan, May Christine V; Chang, Yun Min et al. (2016) Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects. J Med Genet 53:318-29
Gomez-Rodriguez, Julio; Meylan, Françoise; Handon, Robin et al. (2016) Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4. Nat Commun 7:10857
Pathak, Anand; Pemov, Alexander; McMaster, Mary L et al. (2015) Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. Hum Genet 134:775-87
Yokoyama, Tadafumi; Yoshizaki, Ayumi; Simon, Karen L et al. (2015) Age-Dependent Defects of Regulatory B Cells in Wiskott-Aldrich Syndrome Gene Knockout Mice. PLoS One 10:e0139729
Paralkar, Vikram R; Mishra, Tejaswini; Luan, Jing et al. (2014) Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development. Blood 123:1927-37
Gomez-Rodriguez, Julio; Wohlfert, Elizabeth A; Handon, Robin et al. (2014) Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J Exp Med 211:529-43
Rodriguez-Gil, Jorge L; Larson, Denise M; Wassif, Christopher A et al. (2013) A somatic cell defect is associated with the onset of neurological symptoms in a lysosomal storage disease. Mol Genet Metab 110:188-90
Zhao, Ling; Melenhorst, Jan J; Alemu, Lemlem et al. (2012) KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice. Blood 119:1511-21
Hsu, Amy P; Dowdell, Kennichi C; Davis, Joie et al. (2012) Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance. Genet Med 14:81-9

Showing the most recent 10 out of 17 publications